HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ioannis Panagopoulos Selected Research

Pyridinolcarbamate (P23)

9/2020Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors.
11/2016Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas.
11/2015LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13).
10/2015Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
7/2014Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ioannis Panagopoulos Research Topics

Disease

44Neoplasms (Cancer)
07/2022 - 05/2004
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2003
7Genetic Translocation (Chromosomal Translocation)
07/2022 - 12/2002
7Carcinoma (Carcinomatosis)
01/2020 - 03/2006
6Sarcoma (Soft Tissue Sarcoma)
01/2018 - 07/2004
6Chromosome Aberrations (Chromosome Abnormalities)
03/2017 - 11/2010
4Leiomyoma (Uterine Fibroids)
07/2021 - 01/2015
4Glioblastoma (Glioblastoma Multiforme)
06/2020 - 09/2007
3Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2003
3Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor)
01/2018 - 08/2016
3Carcinogenesis
03/2017 - 01/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 10/2008
2Leukemia
01/2021 - 11/2017
2Glioma (Gliomas)
06/2020 - 01/2018
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 06/2002
2Mesothelioma
02/2015 - 08/2013
2Prostatic Neoplasms (Prostate Cancer)
07/2010 - 06/2009
2Hyperplasia
07/2010 - 06/2009
2Melanoma (Melanoma, Malignant)
01/2005 - 10/2002
1Rhabdomyosarcoma
11/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
04/2021
1Bone Cysts (Bone Cyst)
09/2020
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
09/2020
1Angiofibroma
09/2020
1Solitary Fibrous Tumors
09/2020
1Colonic Neoplasms (Colon Cancer)
06/2020
1Pleomorphic Adenoma
05/2020
1Hemorrhage
01/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Hamartoma
11/2019
1Osteoblastoma
09/2019
1Hemangioendothelioma
07/2019
1Trisomy (Trisomies)
05/2019
1Neoplasm Metastasis (Metastasis)
02/2019
1Leiomyosarcoma
01/2018
1Endometrioid Carcinoma
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
11/2017
1Myxoma (Myxomas)
03/2017
1Ependymoma
12/2016
1Insulinoma
11/2016
1Hemangioma (Angioma)
03/2016
1Benign Fibrous Histiocytoma (Dermatofibroma)
11/2015
1Lung Neoplasms (Lung Cancer)
10/2015
1Chondroma (Enchondroma)
07/2015

Drug/Important Bio-Agent (IBA)

30RNA (Ribonucleic Acid)IBA
07/2022 - 03/2005
13Proteins (Proteins, Gene)FDA Link
02/2019 - 07/2004
5Pyridinolcarbamate (P23)IBA
09/2020 - 07/2014
5MethyltransferasesIBA
01/2020 - 07/2015
5RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2019 - 07/2004
5DNA (Deoxyribonucleic Acid)IBA
09/2018 - 09/2007
3MicroRNAs (MicroRNA)IBA
01/2018 - 12/2016
3CollagenIBA
01/2018 - 07/2004
3Telomerase (Telomerase Reverse Transcriptase)IBA
08/2016 - 11/2010
3nuclear pore complex protein 98IBA
01/2007 - 06/2002
2Histones (Histone)IBA
03/2022 - 01/2018
2Transcription Factors (Transcription Factor)IBA
11/2021 - 02/2015
2Carrier Proteins (Binding Protein)IBA
09/2020 - 01/2017
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2019 - 05/2009
2Temozolomide (Temodar)FDA LinkGeneric
11/2018 - 09/2018
2Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2016
2Untranslated RNA (Noncoding RNA)IBA
07/2017 - 10/2008
2CrizotinibIBA
11/2016 - 10/2015
2NucleotidesIBA
01/2015 - 12/2002
2Complementary DNA (cDNA)IBA
11/2010 - 03/2006
2Protein Isoforms (Isoforms)IBA
07/2010 - 06/2009
1Intergenic DNA (Junk DNA)IBA
07/2022
1Nuclear Receptor Co-Repressor 2IBA
03/2022
1P 11 (P-11)IBA
11/2021
1myocardinIBA
11/2021
1Topoisomerase II InhibitorsIBA
01/2021
1Ubiquitin-Specific ProteasesIBA
09/2020
1LumicanIBA
09/2020
1CateninsIBA
06/2020
1TankyrasesIBA
06/2020
1G007-LKIBA
06/2020
1cytidylyl-3'-5'-guanosineIBA
01/2020
1Capsules (Microcapsules)IBA
01/2020
1Messenger RNA (mRNA)IBA
02/2019
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
02/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1Alkylating AgentsIBA
09/2018
1Calmodulin-Binding Proteins (Caldesmon)IBA
01/2018
1DesminIBA
01/2018
1Cyclin D1IBA
01/2018
1CyclinsIBA
01/2018
1Ataxin-2IBA
11/2017
1Janus Kinase 2IBA
11/2017
1Biological ProductsIBA
11/2017
1ChromatinIBA
01/2017
1Histidine (L-Histidine)FDA Link
12/2016
1ProinsulinIBA
11/2016
1DNA Transposable Elements (Element, IS)IBA
09/2016
1isocitrate dehydrogenase (NADP+)IBA
08/2016
1Cellular Retinol-Binding ProteinsIBA
07/2015
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
07/2015
1Codon (Codons)IBA
07/2015
1Protein Kinases (Protein Kinase)IBA
02/2015

Therapy/Procedure

4Therapeutics
04/2021 - 03/2006
2Drug Therapy (Chemotherapy)
03/2006 - 01/2003